Click on the image to sign in or sign up as a member on Wild Apricot.
FountainBlue's Life Science Entrepreneurs' Forum
FountainBlue's Life Science
Entrepreneurs' Forum was launched in September 2006 and provides ongoing
networking and program benefits for 30-90 life science entrepreneurs,
intrapreneurs and investors across Silicon Valley and beyond. These events are
generally held on the third or fourth Mondays of the month, depending on
holiday schedules, from 5:30 - 7:30 p.m., with no meeting scheduled in
December. Our monthly program topics cover the range of life science sub-industries.
Each event will feature a panel of entrepreneurs, intrapreneurs and investors
speaking on challenges and opportunities, providing advice for information to
all.
Members can register for this or future events by visiting http://fountainblue.shuttlepod.org. Partners and Non-Members can register for this event using the PayPal payment option below.
Below is a list
of past and upcoming events for FountainBlue's 2011 life science series. Your
recommendations for sponsors, hosts and speakers (entrepreneurs,
intrapreneurs and investors) are welcome. Please e-mail suggestions to
info@SVLifeScience.com.
Date
Title Speakers
Description
Monday,
January 31, 5:30 until 7:30 p.m. @ UCSC Extension, Sponsored by KPMG
Investor Panel: Predictions for 2011
Facilitator Meredith L.
Warshaw, PhD, CSO, Molecular Image, Chairperson Life Sciences, VC Taskforce,
Adviser, SPARK Program at Stanford University Medical Center
Panelist Ted Driscoll,
Technology Partner, Claremont Creek Ventures and Life Science Angels
Panelist Don Ross,
Managing Director/Founder, HealthTech Capital; Board Director and Co-Chair of
Didactic Committee, Sand Hill Angels; Member, Life Science Angels
Panelist Kevin
Wasserstein, Versant Ventures
It has
been a tough couple of years, but there are investors still standing, still
actively investing in the life science sector. To launch our monthly programs
this year, we have gathered a panel of investors who will speak on trends and
opportunities and challenges in medical devices, medical imaging, healthcare
IT, and other non-capital intensive, non-regulatory solutions, which show
promise as the industry evolves and adapts to a new reality. There will also
be an interactive discussion on the implications of these trends for
entrepreneurs innovating in this space.
Monday,
February 28, 5:30 until 7:30 p.m. @ UCSC Extension
Sponsored
by KPMG
Medical Diagnostics: The Advancements and the Opportunities
Presenting Entrepreneur
Matt Mealiffe, M.D., Founder & CEO, Evinome, LLC
Presenting Entrepreneur
Jason Springs, Geneweave Bio
Medical
diagnostics can range from devices that work with mobile solutions to monitor
and communicate key health indicators to tools made available to surgeons to
dynamically direct treatment real-time to leveraging genomics as indicators
for disease risk. This month, we will cover how diagnostics is quickly
advancing and offering more sophisticated, tailored solutions for patients
and providers alike.
Monday,
March 28, 5:30 until 7:30 p.m. @ UCSC Extension
Sponsored
by KPMG
Maintaining Food Integrity from
Seed to Plate
Facilitator
Gay Timmons, Oh, Oh Organic, Omica
Panelist
Abizer Khairullah, Four Corner Foods
Panelist
Yasmin Tyebjee, CEO, Top Nosh Specialty Foods and Top Nosh Cafe
Presenting
Entrepreneur Robert Carter, CEO, Nikoya Foods Inc.
Presenting
Entrepreneur Brian Witlin, co-Founder and CEO, Shopwell
With
the advancement of technology, the easy access to information, and the
increasing demands of the consumer, the entire food value chain, from
production to manufacturing, treatment and distribution and service, has
undergone revolutionary changes in the past decade. Yet more changes and
innovations are needed, in collaborations between providers throughout the
value chain as well as consumer groups overall. Join us in a conversation
about food innovations and how it is impacting our choices and our overall
health, and find out how we can work together for a higher food standard.
Monday,
April 18, 5:30 until 7:30 p.m. @ UCSC Extension, to be confirmed
Sponsored
by KPMG
Physician
Panel: Partnering with Entrepreneurs to Better Address Patient Needs
Facilitator
Amish Parashar, Stanford University Trans-Disciplinary Program
Panelist
Arthur Douville, Arthur W. Douville, Jr., M.D., Chief Medical Officer, Good
Samaritan Hospital
Panelist
Guy Miller, M.D., Ph.D., co-founder, Chairman and Chief Executive Officer,
Edison Pharmaceuticals
Panelist
Peter G. Milner, MD, FACC, Co-Founder and Executive VP Corporate Development
Optivia Biotechnology and Co-founder CV Therapeutics, ARYx Therapeutics
Presenting
Entrepreneur Subhash Kulkarni, post-doctoral fellow in the Division of
Gastroenterology and Hepatology in Stanford University
Presenting
Entrepreneur Thomas Ruby, PhD, Postdoc fellow, Microbiology and Immunology,
Monack Lab
Physicians
are feeling the pressures of the changing policies, economies and technologies,
which is influencing how they run their practices, and how they work with
their patients. Our panel this month will feature physicians who are
partnering with entrepreneurs, intrapreneurs and investors and proactively
facing these changes, and a set of entrepreneurs who are developing solutions
to support physicians in addressing these issues.
Monday,
May 16, 5:30 until 7:30 p.m. @ UCSC Extension
Sponsored
by KPMG
Technology Acceleration,
Globalization Pressures and the Future of Pharma
Facilitator
William Wright, VP of Operations and Business Development, Bay Area,
California MedTech LLC
Panelist
Diane Oliver, Research Database Strategist at Kaiser Permanente Division of
Research
Presenting
Entrepreneur Matthew Cooper, Ph.D., Chief Science Officer, Syapse
Presenting
Entrepreneur Dave Hodgson, Chief Technology Officer, Tethys Bioscience
Presenting
Entrepreneur Robert Wotring, Co-founder at Innovative Clinical Financing
(ICF) and Program Director and Co-founder at Latin American Clinical Research
Sites
Pharma
companies large and small are faced with the rapid pace of technology
development, both in the labs and in devices and software, and the rapid
acceleration of globalization factors leading to outsourcing and larger
international markets, and other policy and regulatory challenges inherent to
the industry overall. Our seasoned panel of experts will speak on how we are
leveraging our strengths in technology innovation, our phenomenal access to
top-notch academia, and our world-renown innovation ecosystem overall to power the future of pharma, and to take
the longer term view of new markets and opportunities which are more about
personalized medicine than blockbuster drugs.
Monday,
June 20, 5:30 until 7:30 p.m. @ UCSC Extension
Sponsored
by KPMG
Trends
and Opportunities for Medical Imaging
Facilitator
Dennis F. Falkenstein, President and CEO, iOnTrends LLC
Panelist
Tom Thomas, Director of Imaging Systems R&D, Boston Scientific
Panelist
Brian Wilfley, Ph.D., Director, Chief Scientist, Triple Ring Technologies
Presenting
Entrepreneur Caleb Bell, PhD, CEO, Bell Biosystems
Presenting
Entrepreneur Kendall R. Waters, PhD, Manager, Intellectual Property and
Technology Development, Silicon Valley Medical Instruments, Inc.
Medical
imaging solutions are showing great promise in meeting the therapeutic and
diagnostic needs of patients. This month, our panel will focus on successful
medical imaging solutions and raise discussions about the near and long term
potential for the medical imaging industry.
Monday,
July 18, 5:30 until 7:30 p.m. @ Bay Cafe Clubhouse, Palo Alto
Sponsored
by KPMG
The Patient Revolution: How the
Baby Boomers are Impacting the Evolution of the Life Science Industry
Facilitator
William Wright, VP Operations/ Business Development, Bay Area, at California
MedTech LLC
Panelist
Richard Ayllon, Director, Global Business Development, Ventus Medical
Panelist
Don Ross, Healthtech Capital
Presenting
Entrepreneur Ash Damle, Founder and CEO, Medgle
Presenting
Entrepreneur Howard Edelman, President & CEO, VitalWear
Presenting
Entrepreneur Oostur Raza, President & CEO, OmegaGenesis
The
Patient Revolution: How the Baby Boomers are Impacting the Evolution of the
Life Science Industry
With
the aging of the baby boomer generation, and the resultant huge volume of
older, more affluent, more empowered consumers, there have been increasing
demands for delivering life science solutions, from diagnostics to
personalized medicines, from devices to nutragenics. In fact, the volume of
business and interest is becoming so large that it is actually shaping the
direction of the industry! Our panelists this month will discuss the
opportunities ahead for serving consumers, and the technology, policy, and
delivery challenges in doing so.
Monday,
August 8 5:30 until 7:30 p.m. @ Bay Cafe Clubhouse, Palo Alto
Sponsored
by KPMG
Software
Meets Healthcare
Facilitator
Dipankar Ganguly, CEO, BioTelligent
Panelist
Ted Driscoll, Technology Partner, Claremont Creek, Member, Life Science
Angels and Founding Director, Sand Hill Angels
Panelist
John Sotir, Senior Manager, Medical & Test Group, Altera
Presenting
Entrepreneur Parvati Dev, PhD, FACMI, President, Innovation in Learning Inc.,
Distinguished Visiting Scholar, Media-X, Stanford University, Former
Director, SUMMIT Lab, Stanford University School of Medicine
Presenting
Entrepreneur Marco Smit, President, Health 2.0 Advisors
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
Monday,
September 19, 5:30 until 7:30 p.m. @ Bay Cafe Clubhouse, Palo Alto
Emerging
Trends in Medical Devices: Mobile Health, Personalized Medicine and
Consumerization
Facilitator
Gil Peterson, VP Business Development, Triple Ring Technologies
Panelist
Geetha Rao, PhD, Springborne Life Sciences, CEO and Founder, MyMedFax; Vice
President of Strategy and Risk Management, Triple Ring Technologies
Panelist
Frank Ingle, CEO and CTO, Instruments for Science and Medicine
Presenting
Entrepreneur Bronislava Belenkaya, President and Founder, 3S Corporation
Presenting
Entrepreneur Jay Miller, former President and CEO, Zonare Medical Systems
& Vital Images, Inc.
Our annual state of the medical device industry event will focus on
some of the hottest areas in medical devices today: from mobile health
solutions to personalized medicine and consumer devices. Come hear about
these hot new trends, and see how start-ups are leading medical device
innovations around mobile health and personalized medicine, bringing devices
into the hands of consumers.
Monday,
October 17, 5:30 until 7:30 p.m. @ Bay Cafe Clubhouse, Palo Alto
Drug
Delivery Innovations
Facilitator
Robert Mackey, Biopharma Consultant
Panelist
Richard Haiduck, Impel NeuroPharma
Panelist
Matthew Hogan, CFO, Durect
Panelist
Jeffrey Schuster, Triple Ring Technologies
Panelist
Eric Sheu, Ph.D., Chief Scientific Officer for Vanton Research Laboratory,
LLC
Presenting
Entrepreneur Adam Mendelsohn, CEO, Nanoprecision Medical
Presenting
Entrepreneur Harm Tenhoff, Bay Link LLC
This
month, we will cover new devices, tools and services which will help ensure
that drugs are more accurately, more consistently, more effectively
administered and monitored.
Monday,
November 14, 5:30 until 7:30 p.m. @ Bay Cafe Clubhouse, Palo Alto
Personalized
Medicine, Biomarkers, Invitro Diagnostics: The Science Advances, The Business
Opportunities, The Cultural Dilemmas
Facilitator
Audrey Erbes, Erbes and Associates
Panelist
Michael Bates, Vice President, Oncology Research and Development, Cepheid
Panelist
Dean Schorno, CFO, Genomic Health
Presenting
Entrepreneur Giacomo Vacca, Founder and CEO, Kinetic River
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Monday,
December 12 @ Bay Cafe Clubhouse, Palo Alto
Robotics
in Med Tech
Facilitator
Jack Moorman, LeVaunt, LLC
Presenting
Entrepreneur Robert Horst, Ph.D., Vice President of R&D & Cofounder,
Tibion
Presenting
Entrepreneur Mike Ouren, Clinical Development Manager, Restoration Robotics
Presenting
Entrepreneur Bruce Richardson, CEO, Accel Biotech
Presenting
Entrepreneur Dr. Ramesh C. Trivedi, President, Calbiomed International, Inc.
There
are huge opportunities ahead for robotics in medtech, from teleoperations
solutions where humans control each motion to full autonomy machines for
surgical simulation, from task level autonomy where humans define the actions
to supervisory, where humans provide only general direction for a task. This
month we will showcase a range of corporate and early stage innovators in
this space and discuss the opportunities and challenges ahead.
We would like to thank and acknowledge our 2010 and 2011 Life Science sponsors. Our work is not possible without their support, and we encourage you to consider their services.
KPMG
We would like to thank and acknowledge our speakers and sponsors for FountainBlue's 2010 Life Science Entrepreneurs' Forums.
We would like to thank and acknowledge our speakers and sponsors for FountainBlue's 2010 Life Science Entrepreneurs' Forums.
Date
Title
Speakers
Description
Monday,
January 25 at KPMG 500 E. Middlefield Road in
Mountain View
Life Science Angel Investors Panel: Trends for 2010
Sponsored
KPMG
Facilitator Conor Moore,
Partner, KPMG
Panelist Anne DeGheest,
Founder and Managing Director, MedStars, Strategic Advisor at PolyRemedy, Inc
Panelist Stuart Eckmann,
Keiretsu Forum and Life Science Angels
Panelist Don Ross,
Member, Life Science Angels and Sand Hill Angels
Panelist Michael
Weickert, President and CEO, S.E.A. Medical Systems, Inc., Member, Life
Science Angels, Venture Partner, Kranenburg Fund
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The
life science angel investors panelists have been seen a wide range of life
science business models, and have their own thoughts and recommendations on
how to be successful in these challenging times. Topics will include how
early stage companies can position themselves for successful partnerships and
fundings, strategically plan your business based on evolving market needs,
tightly manage cash flow, and build strategic alliances with larger organizations,
angels, research organizations, and other key stakeholders.
As part
of our program this month, we will solicit feedback from all our attendees on
the challenges and opportunities in through facilitated small groups, based
on life science sub-industry topics: Software solutions for the healthcare
industry, medical devices, personalized medicine, medical imaging, and
biopharma.
Monday,
February 22 @ Bay Cafι Clubhouse, 1875 Embarcadero, Palo Alto
Show Me
the Money: Resourceful Ways to Secure Funding for YOUR Life Science Company
in THIS Economy
Sponsored
by KPMG
Facilitator
Maria Walker, Senior Director, KPMG
Panelist
Zachary Antovich, President and CEO, Linkage Biosciences Inc
Panelist
Howard Edelman, President & CEO, VitalWear
Panelist
Oostur Raza, President and CEO, OmegaGenesis
Show Me
the Money: Resourceful Ways to Secure Funding for YOUR Life Science Company
in THIS Economy
Even if
the economic projections are getting more rosy, ask anyone running an early
stage company and they will tell you that times are tough out there! The life
science industry has provided a ray of hope when the economy was at its
darkest.
Historically
known as a slow-moving industry, it has also been more resilient and less
impacted by the recent economic challenges. This month, we will feature a
panel of seasoned entrepreneurs and investors who will share their thoughts
and suggestions on how to secure funding for life science start-ups, from
grant and government funding to angel, venture and corporate funding. They
will share their recent success stories and help you brainstorm how to best
position your company financing.
International
Challenges and Opportunities for Life Science Companies
Sponsored by Morrison Foerster and KPMG
Facilitator
John Bashkin, VP of Strategic Business Development, Triple Ring Technologies
Panelist
William Goure, President and Chief Executive Officer, Acumen Pharmaceuticals
Panelist
Evgeny Zaytsev, General Partner, Helix Ventures
Panelist
Key Shin, Of Counsel, Morrison Foerster LLP
Resilient,
resourceful, life science entrepreneurs are advancing their businesses, and
developing international programs and relationships to better advance their
technology, provide clinical research, and serve their markets. For this
panel, life science entrepreneurs, intrapreneurs and investors on what is
working and what is not, in different international markets.
Monday,
April 19 @ Bay Cafe Clubhouse, Palo Alto
Physician Panel: Partnering with Entrepreneurs to Better Address
Patient Needs
Sponsored
by KPMG and Royse Law Group
Facilitator
Roger Royse, Rose Law Group
Panelist
D. Christopher Chung, M.D., Vice President, Medical Affairs, R&D, and
Engineering, Natus Medical
Panelist
Dr. Arthur Douville, MD, Chair, Advisory Board, Clinsensus, Chair of the
Department of Neurology at Good Samaritan Hospital in San Jose
Panelist
Gary Heit, former Stanford Professor, Staff Neurosurgeon, Dept of
Neurosurgery, Kaiser Permanente Hospital, Redwood City
Panelist
Michael Leong M.D., Interim Executive Director, Pain Center Stanford
Panelist
Brian Wilfley, Chief Scientist and co-Founder, Triple Ring Technologies
Physicians
are feeling the pressures of the changing policies, economies and technologies,
which is influencing how they run their practices, and how they work with
their patients. Our panel this month will feature physicians who are
partnering with entrepreneurs, intrapreneurs and investors and proactively
facing these changes, and a set of entrepreneurs who are developing solutions
to support physicians in addressing these issues.
Monday,
May 17 @ Bowne, Palo Alto
Technology
Acceleration, Globalization Pressures and the Future of Pharma
Sponsored
by KPMG and Royse Law Group
Facilitator
Laurie Allen, Attorney and Director of Southern California Practice, Royse
Law Group Inc.
Panelist
Andrei Blasko, Director of Analytical Method Development, Pain Therapeutics
Panelist
Bill Goure, President and CEO, Acumen Pharmaceuticals
Panelist
David Lustig, VP of Business Development, Optivia Biotechnology Inc.
Pharma
companies large and small are faced with the rapid pace of technology
development, both in the labs and in devices and software, and the rapid
acceleration of globalization factors leading to outsourcing and larger
international markets, and other policy and regulatory challenges inherent to
the industry overall. Our seasoned panel of experts will month will share
innovations in technology development, in collaborations, in business
strategies, and other strategies adapted to keep up with the times.
Monday,
June 14 @ UCSC Extension, Santa Clara
Trends and Opportunities for Medical Imaging
Sponsored by KPMG
Sponsor
Mark Foster, General Counsel and Secretary, Volumetrics Medical Imaging
Panelist
Tobias Funk, PhD, Principal Physicist, Triple Ring Technologies
Panelist
Dave Scott, Director, Imaging Systems, Intuitive Surgical
Presenting
Entrepreneur Mark Foster, General Counsel, Volumetrics
Presenting
Entrepreneur James Peacock, Founder; CEO; Managing Member (Chairman), NociMed
Medical
imaging solutions are showing great promise in meeting the therapeutic and
diagnostic needs of patients. This month, our panel will focus on successful
medical imaging solutions and raise discussions about the near and long term
potential for the medical imaging industry.
Monday,
August 16 @ UCSC Extension
Navigating the FDA Approval Process
Sponsored by KPMG
Facilitator
Sue Rowinski, Sue Rowinski Group, LLC, Diagnostic and Medical Device
Marketing & Reimbursement Consulting
Panelist
Brent Blackburn, President and CEO, Rpaidscan Pharma Solutions, Inc,
Panelist
Dave Lustig, VP of Business Development, Optivia Biotechnology Inc.
Panelist
Melanie Sit, Business Strategist, Optovue
Panelist
Alice Varga, VP of Regulatory Affairs and Quality Systems, Geron
Navigating
the FDA approval processes takes a great idea, exceptional technology,
stellar connections, not to mention patience, fortitude, and no small amount
of luck.
This
month, we will share strategies on how to get your drugs or devices approved
by the FDA, and share how we can collaboratively build a balance between
efficacy, efficiency and effectiveness for patients, physicians and providers
from hospitals to insurance companies to entrepreneurs and intrapreneurs.
Monday,
September 27 @ UCSC Extension in Santa Clara
Emerging Trends in Medical Devices Mobile Health, Personalized
Medicine and Consumerization
Sponsored by KPMG
Facilitator Geetha Rao, PhD, Springborne Life Sciences
Panelist Anne DeGheest, Managing Director and Founder,
HealthTech Capital, Managing Partner and Founder, MedStars
Panelist Dave Scott, Director, Imaging Systems, Intuitive
Surgical, Inc
Panelist Clarence Wilhelm, Director of Software Product
Management, Digital Solutions Group, LifeScan
Presenting Entrepreneur Marc Bandt, CEO, Pelesend
Presenting Entrepreneur Paul To, Emota
Our annual state of the medical device industry event will focus on
some of the hottest areas in medical devices today: from mobile health
solutions to personalized medicine and consumer devices. Come hear about
these hot new trends, and see how start-ups are leading medical device
innovations around mobile health and personalized medicine, bringing devices
into the hands of consumers.
Monday,
October 18 @ UCSC Extension in Santa Clara
Software Meets Healthcare: Forging a Win-for-All
Sponsored by KPMG and Soody Tronson Law Group
Facilitator Soody Tronson, Soody Tronson Law Group
Panelist John Steuart, Managing Director, Claremont Creek
Ventures
Presenting Entrepreneur Ash Damle, Founder and CEO, Medgle
Presenting Entrepreneur Sonia Sousa, Founder and CEO,
Spectroscape
When
done well, the convergence of technology and health care is benefiting
patients, providers, and insurers alike. Our panel this month will profile
software solutions which benefit health service professionals, featuring a
range of solutions from health IT platforms to pharmaceutical tracking,
health monitoring and more.
Monday,
November 15 @ UCSC Extension in Santa Clara
Personalized Medicine, Biomarkers, Invitro Diagnostics: The Science
Advances, The Business Opportunities, The Cultural Dilemmas
Sponsored by KPMG
Facilitator
Brent Treiger, MD, IRX Therapeutics
Panelist
Robert Dunkle, President and CEO A.B.E.S, gene expression analysis
Panelist
Kenneth Fang, MD, Founder, Modus BioMedicine
Panelist
Brandon Steele, Vice President, Commercial Operations, IncellDx, Inc.
Panelist
Kamran Tahamtanzadeh, Founder and CEO, PrognosDx Health, Inc.
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Please join us in thanking our facilitators, speakers, and sponsors for FountainBlue's 2009 life science events.
Angel Panelists:
o Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device
Committees)
o Elaine Heron, Life Science Angels and LabCyte
o Anne DeGheest, MedStars
o Don Ross, Life Science Angels and Sand Hill Angels
Featured Recently-Funded Entrepreneurs:
o Mitchell Mutz, CSO, Amplyx Pharmaceuticals
o Michelle Stecklein Call, CEO, Lypro BioScience
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The life science angel investors weve recruited for this months panel have
been seen a wide range of life science business models, and have their own
thoughts and recommendations on how to be successful in these challenging
times. Topics will include how early stage companies can:
- position themselves for successful partnerships and fundings,
- strategically plan your business based on evolving market needs,
- tightly manage cash flow, and
- build strategic alliances with larger organizations, angels, research
organizations, and other key stakeholders
Facilitator Steven Cui, Of Counsel, Jones Day
Panelist Bonnie Anderson, CEO, Veracyte, Inc.
Panelist Deborah Kilpatrick, Vice President, Market Development, CardioDx,
Inc.
Panelist Geetha Rao, Springborne and Molecular Image
Panelist Mike Richey, Chief Business Officer, Tethys Bioscience
Panelist David Rollo, President, Cell Point LLC
With
advancements in technology and science, we have not only a greater
understanding of people and their various diseases, but we are also better
understanding the human genome, and are making progress in creating
personalized medicines to customize treatment and even preventive care for
people.
But these advancements are also raising questions: what's the myth, and
what's the science? What's in the research, blue-sky phase, and who is
providing what REAL solutions now? And where's the money in it? What does it
mean for the average person? Our panel will facilitate a discussion covering
these topics and more.
Facilitator John Bashkin, Triple Ring Technologies
Panelist Rob Abrams, Operating Partner, Sanderling Ventures, Former Head of
Business Development, Boston Scientific
Panelist Dave Scott, Senior Product Manager, Vision Systems, Intuitive
Surgical
Panelist Niamh Pellegrini, General Manager, LifeScan, a J&J Company
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share
their R&D strategies, and their thoughts on which markets will be hot.
Facilitator Myriam Curet, MD, Stanford University, Chief Medical Advisor,
Intuitive Surgical
Panelist Shahram S. Gholami, M.D., Urological Surgeon
Panelist Gary Heit, PhD, MD, former Assistant Professor, Director of
Functional Neurosurgery, Dept of Neurosurgery, Kasier Redwood City
Panelist Frank Lai, MD, Department of Urology, El Camino Hospital
Panelist Michael Leong, MD, Anesthesiologist
Panelist James Lilja, PhD, OBGYN
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share their
R&D strategies, and their thoughts on which markets will be hot.
Facilitator Joyce Chiarenza, Chiarenza Consulting, L.L.C., Certified Clinical
Compliance Professional, and Instructor, UCSC Extension
Panelist Walt Cecka, Senior Director, Program Management, Triple Ring
Technologies
Panelist Krishna Ghosh, VP of Quality and Compliance, Arbor Vita
Corporation
Panelist Jacques Ginestet, Director, Sustaining Engineering, LifeScan
Panelist Chris Panarties, Sr. Director, Reimbursement, Health Economics and
Pricing, NeurogesX
Panelist Susan Rowinski, Sue Rowinski Group LLC, Reimbursement &
Marketing Consulting
Success
in today's life science regulatory environment requires balancing the
management and impact of federal, state and local policies on the rapid pace
of technology development and science advancement in today's life science businesses.
This month's seasoned life science specialists will share their perspectives
on the impact and interplay of regulatory requirements on reimbursement,
technology development, science exploration and other business functions for
life science entrepreneurs, intrapreneurs and investors.
Facilitator Dick Haiduck
Panelist Rich Ferrari, Partner, De Novo Ventures
Panelist Stevan Jovanovich, CEO, Microchip Biotech
Panelist Yvonne Linney, VP, Strategy, Marketing and Business Development,
Life Sciences Solutions Unit, Agilent
Panelist Glen Sato, Partner Cooley Godward Kronish, LLC
Panelist Charles Versaggi, CEO, OsteoCorp
Presenting Entrepreneur: Richard Lotti, CEO, Quadra Vascular
Presenting Entrepreneur: Dr. Sampath Srikanth, DermDx's CEO
Presenting Entrepreneur: Roger Thomas, CEO, Topavance
Even
when times were flush, it was difficult for life science entrepreneurs and
execs to develop a comprehensive strategy that could be well executed. The
additional challenges of regulatory, clinical trials, manufacturing,
distribution, etc., add to the normal business challenges of people,
technology and markets. Yet, no matter what the circumstances, resourceful
entrepreneurs, intrapreneurs and investors find a way to make it work. This
month's panel will share the creative strategies that are working for them,
and the additional work they need to do to navigate today's challenging
business environment.
Facilitator Peter Berger II, CEO, Alitora
Panelist Ian Irwin, Director of Drug Discovery, Parkinsons Institute
Panelist Michael ODonnell, Partner, Wilson Sonsini
Panelist Ted Spack, Managing Director, Fast Forward LLC
Panelist Craig Taylor, Co-Founder and General Partner, Alloy Ventures
Presenting Entrepreneur: Yadon Arad, Tiara Pharmaceuticals
Presenting Entrepreneur: Julia OConnor, CEO, Accelalox Inc.
Presenting Entrepreneur: David Zarling, CEO, Colby Pharmaceuticals
Life
science professionals are faced with the usual challenges in developing,
testing, manufacturing, approving and distributing biopharma solutions from
drug discovery to therapeutics to enabling platforms. These unique challenges
extend the time from inception to market, yet the companies that successfully
navigate these challenges are companies to watch bringing financial returns
to companies, and products and services to markets.
With the dramatic and rapid changes in policy and administration and outlook
toward the life science industry overall, new interest has been placed on how
to identify the key players in the biopharma market, and facilitate forward
progress for people and organizations in this industry. This months panel
will address todays unique challenges and share successes worth noting.
Facilitator Geetha Rao, Springborne Life Sciences
Panelist Joseph Heanue PhD, President, Triple Ring Technologies
Panelist Frank Ingle, Senior Research Fellow, Electrophysiology Division,
Boston Scientific
Panelist Sharbel Noujaim, VP of Product Engineering, LifeScan
Presenting Evelyn Hu, Chief Marketing Officer and Director of Product
Development, iShoe
Presenting Tom Moore, President and CEO, Silicon Valley Medical Instruments
Presenting Michael Weickert, President and CEO at SEA Medical Systems, Inc
Medical
Device Advances: From Implantables to Surgical Tools, From Diagnostics to
Therapeutics
This month we will highlight successful medical device solutions from
implantables to clinical equipment and also cover partnering across academia
and industry to advance the industry, and the future of medical device
industry in general.
Monday,
October 19 @ Intuitive Surgical
Software
Meets Healthcare Services: Health IT Platforms, Pharmaceutical Tracking,
Remote Monitoring and Beyond
Facilitator Russell Singleton, President and CEO, Molecular Image
Panelist Shannon Kelley, Director of Marketing, Intuitive Surgical
Panelist John Steuart, Claremont Ventures
Panelist Evgeny Zaytsev, Helix Ventures
Panelist Steve Douglas, CEO, Data Physics Research
Presenting Entrepreneur Rohan G.F. Coelho, CEO, Rexanto
Presenting Entrepreneur Anthony Gioeli, CEO, MedAttune
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
Facilitator Linda K. Molnar, LKM Strategic Consulting
Panelist Doug Dolginow, PhD, BOD, Advisor, Founder CSO/CMO, Veracyte, Inc,
and CEO and BOD, NanoValent
Panelist Kimberlee Caple, Vice President, Genetic Systems Division, Applied
Biosystems, part of Life Technologies Corporation
Panelist Ted Driscoll, Venture Partner, Claremont Ventures; Active Member,
Life Science Angels; Founding Director, Sand Hill Angels
Panelist Kendall Wu, Product Manager, Cytogenetics Portfolio, Affymetrix
Presenting Entrepreneur Richard A. Goozh, Sr. VP, Strategy & Finance,
Wave 80 Biosciences; Managing Director, Cambrian Partners
Presenting Entrepreneur Dick Haiduck, Partner to the CEO, Implicit
Bioscience and Compugen, advisor to the Queensland Australia government
Presenting Entrepreneur Massimo Bocchi, Chief Technology Officer, MindSeeds
Laboratories s.r.l. and Fulbright scholar
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Monday,
December 21
Holiday
Break
n/a
Below is a calendar for our 2008 life science entrepreneurs' forums, to take place in the evenings from 5:30 - 7:30 p.m.
Date
Title
Facilitator and Panelists
Tuesday, January 22
Life Science Angels Panel: Investment Trends in 08
Facilitator Aliki Helman, serial entrepreneur and former corporate exec
Panelist Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device Committees)
Panelist Elaine Heron, Life Science Angels and LabCyte
Panelist Bob Molinari, MedStars
Panelist Don Ross, Life Science Angels and Sand Hill Angels
Tuesday, February 19
Incubating Life Science Companies
Facilitator Ted Spack, SRI International
Panelist Gayle Fagan, Managing Director, San Jose Biocenter
Panelist Jim Rurka, co-founder of Blanca Pharmaceuticals
Panelist Dave Yeomans, Trigemina Inc.
Monday, March 17
Partnering with Life Science Corporations
Facilitator Bruce W. Jenett, Partner, DLA Piper
Panelist Rob Abrams, Vice President New Business Development / New Ventures, Boston Scientific
Panelist Martin Doyle, Director of Mergers and Acquisitions, Applied Biosystems
Panelist Graeme R Martin Ph.D., Takeda Research Investment Inc
Panelist Ali Nasser, Director of Business Development, Roche Molecular Systems
Monday, April 21
Trends in Pharma
Facilitator Ted Spack, Senior Director of Business Development, SRI International
Panelist Dick Haiduck, Partner to the CEO of Implicit Bioscience and Cytopia
Panelist David Summa, CEO, Acumen Pharmaceuticals
Panelist Dr. Nicholas Saccomano, Senior Vice President of Worldwide Exploratory Science and Technology, Pfizer
Monday, May 19
Trends in the Medical Device Development
Facilitator Bruce W. Jenett, Partner, Co-Chair, Global Life Sciences Sector, DLA Piper US LLP
Rob Abrams, Operating Partner, Sanderling Ventures; former Vice President New Business Development/ New Ventures, Boston Scientific Corporation
Richard M. Ferrari, Managing Director, De Novo Ventures
William T. Harrington, MD, Partner, Three Arch Partners
Geetha Rao, Serial Medical Device Entrepreneur and Executive, Springborne Life Sciences and Triple Ring Technologies
Monday, June 16
Holiday Break
n/a
Monday, July 21
Holiday Break
n/a
Monday, August 18
Issues in Collaborative Development
Facilitator/moderator: Alan Schwartz-Ocio, Of Counsel, DLA Piper LLP Panelists: Adam Bristol, Investor, Biotechnology Value Fund
Jeff Jonker, Director of Business Development, Genentech
Jim I McLoughlin, Executive Director, Worldwide Business Development & Pfizer Venture Capital; Pfizer Inc. - Biotherapeutics and Bioinnovations Center
John Wulf, EVP & CBO, Trellis Bioscience
Monday, September 15
From Strategy to Execution: Growing Your Company to the Next Level
Facilitator Russell M. Singleton, Ph.D., President and CEO, Molecular Image, Inc.
Robert Abrams, Operating Partner, Sanderling Ventures
Bill Goure, Ph.D., COO, Acumen Pharmaceuticals
David Horwitz, M.D., Ph.D., World Wide Vice-President of Clinical Affairs and Evidence-Based Medicine, LifeScan
Ed Torres, Managing Director, Lilly Ventures
Monday, October 20
Show Me the Money: from Angels to Grants to VCs
Facilitator Geetha Rao, Springborne Life Sciences and Triple Ring Technologies
Panelist Adam S. Bristol, Ph.D., Biotechnology Value Fund, L.P.
Panelist Gino Di Sciullo, Ph.D., Charter Life Sciences
Panelist Dr. Evgeny Zaytsev, Partner, Asset Management Company
Panelist Allan W. May, Life Science Angels
Panelist Tom Rodgers, Principal, Advanced Technology Ventures
Monday, November 17
International Partnerships for Life Science Execs
Facilitator Simon Taylor, President, ACN Securities
Panelist Rinko Ghosh, Senior VP of Business Development and Alliance Management, Nektar Therapeutics
Panelist Phyllis Whiteley, PhD, Executive in Residence, Mohr Davidow Ventures
Panelist David Zarling, CEO, Colby Pharmaceutical Company
Other Panelists to be confirmed
Monday, December 15
Holiday Break
n/a
We are grateful to our partners and speakers for our 2007 programs and proudly acknowledge them below.
Date
Title
Facilitator
Tuesday, February 20
Corporate Investments in Life Science Companies
Facilitator Geetha Rao Panelist Linda Greub, Business Development, Applied Biosystems Panelist Eran Raber, Director, New Business and Venture Investments, Agilent Technologies Panelist Simon Greenwood, Ph.D., Senior Manager, Business Development, Genentech, Inc.
Monday, March 19
Positioning Your Life Science Company for Outside Funding
Facilitator Geetha Rao Panelist Brian Boyer, Perkins Coie LLP Panelist John Cornwell Life Science Angel Panelist Ken Martin, Onset Ventures Panelist David Miller Founder, InnoSpine
Monday, April 16
R&D Funding Opportunities
Facilitator Brian Boyer, Perkins Coie LLP Panelist Jeff Fairman, founder and senior research director, Juvaris Panelist Tom Gutshall, Founder and Former CEO, Current Chairman of Cepheid Panelist David Light, Business Builders
Tuesday, May 22
Trends in Life Science Investing
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Andrew Farquharson, InCube Ventures Panelist Nina Kjellson, Partner, InterWest Partners Panelist John Maroney, General Partner, Delphi Ventures Panelist Kevin Wasserstein, Versant Ventures
Monday, June 18
Successful Entrepreneur Panel
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Brent Contstantz, Skeletal Kinetics LLC Panelist Charlie Wen, Current founder and CTO, Tensegrity, former CEO of OrthoClear, Karegiver, former director of engineering and Align Technology Panelist Tony Zhang, PhD President, CEO and Chairman Formurex
Monday, July 16
Your Company's Value Proposition
Facilitator Sharon Lewis, President, Strategic Impact, Inc. Panelist Valli Bindana, President & Creative Director, KreativeVistas Panelist Ruth Cavagnaro, CEO, ChorusWare (Astia Portfolio Company) Panelist Chisato Ishii, Investment Partner, JAIC America, Inc. Panelist Ken Macrae, PhD, MD, EVP and Serial CEO Panelist John Reed, Global Operations, Agilent Technologies Panelist - Fred Seddiqui, CEO, Avantis Medical Systems, Inc.
Monday, August 20
Outsourcing Options for Life Science Companies
Co-Facilitator Simon Goldbard, Ph.D., Corex Co-Facilitator Matt Perez, NearSoft Panelist Oren Beske, Ph.D., Director, Aragen Bioscience, Inc. Panelist Simon Greenwood, Senior Manager, Business Development, Genentech, Inc. Panelist Alshad S. Lalani, Ph.D., Director, Preclinical & Translational Oncology, Novacea, Inc. Panelist Angie You, COO Ren Pharmaceuticals
Monday, September 17
Navigating Government Regulations
Facilitators Linda Judge and Alan Schwartz Ocio from DLA Piper Panelist Anar Kotadia, MSS Consulting and Chair San Francisco Bay Area Chapter, Regulatory Affairs Professionals Society, formerly with Abbott, (with medical device perspective), RAPS Panelist Alan Jacobs, Acorn Biomedical (early stage clinical development) Panelist Geetha Rao (with a medical device perspective ) Panelist Rick Srigley, CEO & President of Aragen Bioscience
Monday, October 15
Marketing and Sales Operations for Life Science Entrepreneurs
Facilitator, Sharon Lewis, Founder and President, Strategic Impact, Inc. Panelist, Neelam Vaidya, Co-Founder and CEO, ChiroSolve Panelist, Rajiv Mehta, Co-Founder and CEO, Zume Life Panelist, Martin Babler, Entrepreneur, former VP Sales and Marketing Immunology, Genentech Inc. Panelist, Michael Mitchell, VP Marketing, Cantimer Panelist, Dan Galles, General Partner, HLM Venture Partners
Monday, November 19
Building An A+ Life Science Management Team
Facilitator Roy Fiebiger, Managing Partner, Sanford Rose Associates Panelist Chuck Brynelsen, CEO of IntraPace Panelist Dan Galles, General Partner, HLM Venture Partners Panelist Jonathan Goldman, MD., CMO Panelist Zack Scott, Director, Burrill & Company
Monday, December 17
Holiday Break
n/a
We are grateful to each of our 2006 facilitators and panelists for their participation and support and proudly acknowledge them below.
Date
Title
Facilitator
Monday, September 18
Life Sciences Entrepreneurs' Forum, Theme: Bringing the Product to Market
Melinda Richter, San Jose Bioscience Center Michael Shuster, Fenwick & West
Monday, October 16
Life Sciences Entrepreneurs' Forum Theme: Preparing for Outside Investors
Ken Macrae Geetha Rao Sergio Garcia
Monday, November 20
Life Sciences Entrepreneurs' Forum Theme: Building an A+ Life Science Management Team
Roy Fiebieger Tom Afzal, CEO of SpinalKinetics Andrew Farquharson, InCube Mike Hall, Latham & Watkins
Monday, December 18
Life Sciences Entrepreneurs' Forum: Holiday Break
n/a
Testimonials about FountainBlue's
Life Science Entrepreneurs' Forum
I have enjoyed the content and the networking
opportunities provided by FountainBlue for the life science community, and felt
like it has helped me to be in the flow of what is happening in the Bay Area.
By actively participating, I received some tangible results: I have found
people to hire, I found people new clients, and I formed relationships that
have been helpful to my client companies.
I was honored to be surrounded by the other
panelists you chose to include. It is not often that I can be surrounded
by individuals who are so knowledgeable and insightful regarding drug delivery
technologies in a setting that fosters genuine high-level discussions regarding
so many of the important aspects that our industry is dealing with.
I very
much enjoyed the life science entrepreneurs' forum, and appreciate your warm
welcome to the FountainBlue community.
The FountainBlue organization, led by
Linda Holroyd, offers an array of insightful events focused on career
development, networking and entrepreneurialism that
is unparalleled in the Silicon Valley. They're always rich with
senior-level speakers and panelists who deliver one-of-a-kind performances,
mostly due to the unique mix of talent Linda pulls together.
I meet numerous
new contacts who helped me extend my own network while asking nothing in
return. The atmosphere at the FountainBlue events is always electric and
stimulating.
For any Silicon Valley professional, the experience will boost
your career and offer new pathways to success.. I also appreciate the meeting
follow-up notes and think that they complement the meeting well, and greatly
improve the experience.
FountainBlue's
events stand out among the rest as the quality of the audience
and the program are equally impressive. I look forward to attending future
FountainBlue events as I think they will be instrumental in helping me to
achieve my professional goals in the Life Science industry.
It never fails that
even when I think a forum topic may be of little interest to me, I find out so
much and become very involved. It speaks well not only for your panelists and
their ability to share the value of their expertise and information in a manner
pertinent to all attendees, but also to FountainBlue's exceptional ability to
choose the right speakers on topics of importance. I always come away feeling
so enlightened with new ideas.
FountainBlue's life sciences forums set themselves apart in that they address and connect multidisciplinary life sciences executives and investors. This is inclusive of, but not limited to medical devices, BioPharma, and emerging technologies such as wireless and nanotechnology applications in healthcare. We connect the companies' executives of various sizes that have different capabilities i.e. discovery vs. development to enhance relationships and foster productive discussions to promote common goals and expectations.
